000 01325 a2200385 4500
005 20250517082251.0
264 0 _c20180129
008 201801s 0 0 eng d
022 _a1600-0625
024 7 _a10.1111/exd.12986
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBraegelmann, Christine
245 0 0 _aSpleen tyrosine kinase (SYK) is a potential target for the treatment of cutaneous lupus erythematosus patients.
_h[electronic resource]
260 _bExperimental dermatology
_c05 2016
300 _a375-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aCase-Control Studies
650 0 4 _aCells, Cultured
650 0 4 _aCytokines
_xmetabolism
650 0 4 _aHumans
650 0 4 _aLupus Erythematosus, Cutaneous
_xenzymology
650 0 4 _aPhosphorylation
650 0 4 _aSyk Kinase
_xmetabolism
700 1 _aHölzel, Michael
700 1 _aLudbrook, Valerie
700 1 _aDickson, Marion
700 1 _aTuran, Nil
700 1 _aFerring-Schmitt, Sandra
700 1 _aSternberg, Sonja
700 1 _aBieber, Thomas
700 1 _aKuhn, Annegret
700 1 _aWenzel, Joerg
773 0 _tExperimental dermatology
_gvol. 25
_gno. 5
_gp. 375-9
856 4 0 _uhttps://doi.org/10.1111/exd.12986
_zAvailable from publisher's website
999 _c25765367
_d25765367